Oramed Pharmaceuticals
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1185 Avenue of the Americas Fl 3, New Yo...Phone Number
(844) 967-2633Website
www.oramed.comRevenue
-Stock Symbol
ORMPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Oramed Pharmaceuticals
Oramed Pharmaceuticals, or Oramed (), is a publicly traded company engaged in the development of oral drug delivery systems most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.Explore more
Oramed Pharmaceuticals Org Chart
AG
Chief Financial Officer
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oramed Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Oramed Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Oramed Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Oramed Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Oramed Pharmaceuticals
Click to see if Oramed Pharmaceuticals had a recent Job posting/layoffs
Oramed Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Oramed Pharmaceuticals has new funding data
Product Launch: Get notified when Oramed Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Oramed Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Oramed Pharmaceuticals
Compare insights from companies similar to Oramed Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oramed Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oramed Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oramed Pharmaceuticals.
Oramed Pharmaceuticals financials insights
Gather financial insights about Oramed Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$36.9M
Oramed Pharmaceuticals Tech Stack
A closer look at the technologies used by Oramed Pharmaceuticals
See more technologies
Most Recent Scoops
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oramed Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Oramed Pharmaceuticals, or Oramed (), is a publicly traded company engaged in the development of oral drug delivery systems most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.... Read More
